Probiotics in primary prevention of atopic diseases
OwnerErika Isolauri, Seppo Salmineninventors
Life of this patent
Estimating the term…
Abstract
The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bacteria, beneficial microbes of the healthy gut flora, pre- and postnatally to children at high risk of atopic diseases. In an embodiment, probiotic bacteria are administered to a pregnant woman at least two weeks before infant delivery and after delivery, probiotic bacteria are administered to the newborn infant for at least two months. The amount of probiotic bacteria administered is about 1×108 to about 1×1010 colony forming units of the probiotic bacteria.
Claims2
A method for prevention of atopic diseases selected from the group consisting of atopic eczema, allergic rhinitis and asthma in an infant at high risk of said atopic diseases, comprising
- administering to a pregnant woman a daily dose of live probiotic bacteria in an amount of about 1×108 to about 1×1010 colony forming units of the probiotic bacteria for at least two weeks before infant delivery, and
- after infant delivery, administering directly to the newborn infant of said pregnant woman a daily dose of live probiotic bacteria in an amount of about 1×108 to about 1×1010 colony forming units of the probiotic bacteria for at least 2 months;
- wherein said probiotic bacteria are selected from the group consisting of Lactobacillus casei spp. rhamnosus ATCC 53103 and Bifidobacterium lactis Bb-12.
Dependencies are inferred from the claim text.